VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the first quarter ended March...

Related Keywords

California ,United States ,Canada ,Texas ,London ,City Of ,United Kingdom ,Singapore ,Belgium ,America ,Daniel Sheres ,Louise Batchelor Debra Daglish ,Axel Imhof ,Scott Powell ,Devin Devoue ,Sharon Ballesteros ,Kristy Valdivia ,Tom Butera ,Cameron Reynolds ,Siebert Hall ,Terig Hughes ,York Stock Exchange ,Linkedin ,Volition Veterinary Team ,Twitter ,Volition Veterinary Diagnostics Development ,Volitionrx Limited Capital Markets Day ,Exchange Commission ,Toll International ,Youtube ,New York Stock Exchange ,Securities Exchange ,Heska Corporation ,Facebook ,Volitionrx Limited First Quarter ,Capital Markets Day ,Product Manager ,Marketing Manager ,Global Accounts Manager ,Volition Veterinary ,Vet Cancer Screening Test ,Vet Cancer Test ,Proteomics Approach ,Epigenetic Profiling ,Professor Axel ,Business Update Conference Call Date ,Chief Executive Officer ,Chief Financial Officer ,Executive Vice President ,Investor Relations ,Volitionrx Limited Capital Markets ,Debra Daglish ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,Volitionrx Limited ,